The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health - A Randomized, Double-Blind, Placebo-Controlled Study
The goal of this clinical trial is to learn if Quercefit® or Ubiqsome™ can improve markers of healthy aging, blood sugar control, and heart health in older adults. It will also learn about the safety of these supplements.
The main questions it aims to answer are:
Researchers will compare Quercefit® (500 mg/day), Ubiqsome™ (300 mg/day), and a placebo (a look-alike capsule with no active ingredient).
Participants will:
Take their assigned capsules (Quercefit®, Ubiqsome™, or placebo) twice daily for 12 weeks
Go to a preferred clinic at the start and end of the study for a fasting blood draw
Complete at-home tests:
Grip strength testing (using a device mailed to them)
Online surveys about fatigue and quality of life
Report any side effects and keep track of supplement use
VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements
Oral Supplement in Older Adults to Support Physical Fitness and Mental Well-being
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults